Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MOSAIC ONCOLOGY AS
AS
Active
Org 917032637
Storgata 61, 4307 Sandnes
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2016
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 31K
-98% vs 2023
EBITDA margin
-97.3%
-3068% vs 2023
Equity ratio
-94.0%
Financial strength
Net profit 2024
NOK -44K
-121% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
-1M
-100%
2021
0M
+100%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 31K
-98%
EBITDA
NOK -30K
-3068%
Net profit
NOK -44K
-121%
Total assets
NOK 5K
-89%
Equity
NOK -5K
-113%
Employees
0
—
Company information
Legal name
MOSAIC ONCOLOGY AS
Org number
917032637
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
15. april 2016
Share capital
NOK 90 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og ett styremedlem i fellesskap.
Company purpose
Å drive med utvikling, lisensiering og salg av medisinsk diagnostiske tester.
Contact
Address
Storgata 61, 4307 Sandnes
Email
kontakt@mosaicmedical.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Sandnes
All Norway companies
Revenue
NOK millions
0M
2M
5M
7M
9M
8M
2020
3M
2021
2M
2022
2M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
-1M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
8 200
2 582
1 866
1 669
31
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−427
−696
−96
−1
−30
Depreciation & amort.
−16
−16
−16
−16
−14
EBIT
−444
−713
−112
−17
−44
Net financials
0
−0
−2
−2
0
Profit before tax
−443
−713
−114
−20
−44
Tax
−0
−99
−0
−0
−0
Net profit
−443
−613
−114
−20
−44
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 509
543
284
49
5
Equity
786
172
58
39
−5
Long-term debt
0
0
0
0
0
Short-term debt
724
370
226
10
10
Total debt
724
370
226
10
10
Financial ratios
5-year trend
EBITDA margin
-97.3%
This company
15.8%
Market median
-716% vs market
2020
2024
Equity ratio
-94.0%
This company
38.2%
Market median
-346% vs market
2020
2024
Return on equity
-4368100.0%
This company
18.4%
Market median
-23739774% vs market
2020
2024
Net profit margin
-141.6%
This company
8.1%
Market median
-1848% vs market
2020
2024
Asset turnover
5.83×
This company
1.12×
Market median
+421% vs market
2020
2024
Debt / equity
2.06×
This company
0.62×
Market median
-232% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SS
Solveig Stråtveit
Chief Executive Officer
Chief Executive Officer
2017
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
SA
Simen Andre Aarsland Øgreid
Board of Directors
2020
DS
Dagfinn Steinar Øgreid
Chairman
2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Citron As
Company
33.33%
33.33%
2022
Bamsic As
Company
33.33%
33.33%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Bamsic As
MOSAIC ONCOLOGY AS
(this company)
Board network connections
Board members of MOSAIC ONCOLOGY AS also hold positions in
0
other companies.
Person
Role here
Other companies
Solveig Stråtveit
Chief Executive Officer
0 companies
Simen Andre Aarsland Øgreid
Board of Directors
0 companies
Dagfinn Steinar Øgreid
Chairman
0 companies